IRLAB Announces Invitation to Presentation of the Interim Report for Q1 2022

2 years ago

GOTHENBURG, SWEDEN / ACCESSWIRE / May 4, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)IRLAB Therapeutics AB (publ) today announced that the…

Number of voting rights as of May 4, 2022

2 years ago

Nicox SASociété anonyme with a registered capital of € 43,223,135 Head Office:DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S.…

Renowned Entrepreneur Vinod Ramchandra Jadhav Breaks Ground for the Renovation of Maharashtra Sahitya Parishad Library Cum Study Center

2 years ago

PUNE, INDIA / ACCESSWIRE / May 4, 2022 / Dubai-based entrepreneur Mr. Vinod Ramchandra Jadhav did the ground-breaking for the…

Valneva Initiates Heterologous Booster Trial of Inactivated, COVID-19 Vaccine Candidate

2 years ago

Saint-Herblain (France), May 4, 2022 – Valneva SE, a specialty vaccine company, today announced the initiation of a heterologous booster…

NLS Pharmaceutics Achieves 90% Enrollment Milestone in Quilience(R) Phase 2a Clinical Trial for Patients with Narcolepsy

2 years ago

Since the interim results were released in March, patient enrollment has nearly doubledOf the 60 patients planned for the study,…

Bavarian Nordic to Host First Quarter 2022 Results Conference Call and Webcast

2 years ago

COPENHAGEN, Denmark – May 4, 2022 - Bavarian Nordic A/S (OMX:  BAVA) will announce its 2022 first quarter results on…

Xcelerate, Inc. Expands IP with Acquisition of Patent Portfolio

2 years ago

MAULDIN, SC / ACCESSWIRE / May 4, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) today announced that it signed a purchase…

Top 12 Emerging Gene and Cell Therapy Technologies Likely to Impact Patient Care Announced in Annual “Disruptive Dozen” from Mass General Brigham

2 years ago

Breakthroughs range from restoration of sight and increasing the supply of donor organs, to treating brain cancer, hearing loss, and…

Evotec SE to Announce Results for the First Quarter 2022 on 11 May 2022

2 years ago

HAMBURG, GERMANY / ACCESSWIRE / May 4, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) will…

Umoja Biopharma Presents Data on its Synthetic Cytokine Receptor Platform at the International Society for Cell and Gene Therapy Annual Meeting 2022

2 years ago

RACR-induced cytotoxic innate lymphocytes permit the expansion and differentiation of iPSCs with fewer limitations, leading to a more cost-effective manufacturing…